HAEMONETICS CORP - Common stock, $.01 par value per share (HAE)

CUSIP: 405024100

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / Common stock, $.01 par value per share
Shares outstanding
46,480,294
Total 13F shares
53,625,853
Share change
-879,811
Total reported value
$3,115,125,238
Put/Call ratio
157%
Price per share
$58.08
Number of holders
240
Value change
-$26,066,940
Number of buys
118
Number of sells
104

Quarterly Holders Quick Answers

What is CUSIP 405024100?
CUSIP 405024100 identifies HAE - HAEMONETICS CORP - Common stock, $.01 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of HAEMONETICS CORP - Common stock, $.01 par value per share (HAE) as of Q4 2017

As of 31 Dec 2017, HAEMONETICS CORP - Common stock, $.01 par value per share (HAE) was held by 240 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 53,625,853 shares. The largest 10 holders included BlackRock Inc., Vanguard Group Inc, WELLINGTON MANAGEMENT GROUP LLP, VICTORY CAPITAL MANAGEMENT INC, WELLS FARGO & COMPANY/MN, Neuberger Berman Group LLC, DIMENSIONAL FUND ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, HealthCor Management, L.P., and STATE STREET CORP. This page lists 240 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.